Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 28, 2010
3D QSAR of aminophenyl benzamide derivatives as histone deacetylase inhibitorsMahipal, Om Prakash Tanwar, C Karthikeyan, et al.Journal of Biomedical Research|March 10, 2017
Force degradation behavior of glucocorticoid deflazacort by UPLC: isolation, identification and characterization of degradant by FTIR, NMR and mass analysisRajesh Deshmukh, Lata Sharma, Muktika Tekade, et al.Ayu|June 5, 2012
Antiobesity effect of Stellaria media against drug induced obesity in Swiss albino miceVijay R Chidrawar, Krishnakant N Patel, Navin R Sheth, et al.Scientific Reports|November 4, 2021
Lead optimization of novel quinolone chalcone compounds by a structure-activity relationship (SAR) study to increase efficacy and metabolic stabilityJames Knockleby, Aïcha Dede Djigo, Indeewari Kalhari Lindamulage, et al.Bioorganic & Medicinal Chemistry|February 18, 2014
Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitorsDigambar Kumar Waiker, Chandrabose Karthikeyan, Vasanthanathan Poongavanam, et al.Bioorganic & Medicinal Chemistry Letters|June 19, 2010
A new approach for PEGylation of dendrimersHemant Khambete, Surya P Gautam, C Karthikeyan, et al.Current Drug Targets|February 27, 2014
Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's diseasePrinci Jain, Chandrabose Karthikeyan, N S Hari Narayana Moorthy, et al.Scientific Reports|September 2, 2017
Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 functionI Kalhari Lindamulage, Hai-Yen Vu, Chandrabose Karthikeyan, et al.Recent Patents on Anti-Cancer Drug Discovery|August 21, 2014
Advances in chalcones with anticancer activitiesChandrabose Karthikeyan, Narayana S H Narayana Moorthy, Sakthivel Ramasamy, et al.Medicinal Chemistry (Shariqah (United Arab Emirates))|May 14, 2008
Quantitative structure activity analysis of 2-alkoxydihydrocinnamates as PPARalpha/gamma dual agonistP Manoj Kumar, R Hemalatha, S C Mahajan, et al.Pageof 7